If you’re ready to make the life-altering decision to obtain permanent birth control, check out our list of 4 easiest forms of permanent birth control for men and women. While many people are actively ...
In the 21 years since launching her company, Lee-Sepsick has raised millions of dollars, taken her company public and invented new cervical cancer screening tools, fertility devices and one of the ...
Many women spend decades using birth control of one kind or another, except for when they’re trying to conceive or are pregnant. So when you know you’re done having babies or if you plan to stay child ...
ATLANTA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (FEMY) (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and ...
Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth ...
Continued rollout of FemBloc, the breakthrough non-surgical permanent contraceptive solution, expands the Company’s presence in key European ...
- Pivotal clinical trial to begin in the third quarter of 2023- ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women’s needs worldwide by ...
TipRanks on MSN
Femasys Secures Major Order for FemBloc Launch
On November 6, 2025, Femasys Inc. announced a significant initial order valued at approximately $500,000 USD for the commercial launch of FemBloc Permanent Birth Control in France and the Benelux ...
Stocktwits on MSN
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing
Femasys secured FDA approval to proceed with the final phase of its pivotal FemBloc trial, a key step toward U.S. market ...
WESTMINSTER, Colo. — Republicans' sweeping wins in November mean an uncertain future for women's reproductive rights. Now, many women are taking things into their own hands. In the weeks since the ...
ATLANTA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (FEMY) (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results